Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Taylor

Showing results (71-80 of 246) with videos related to

Pageof 25
Sort By:
Annals of the Rheumatic Diseases|August 24, 2011
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trialPeter C Taylor, Emilia Quattrocchi, Stephen Mallett, et al.
Rheumatology (Oxford, England)|August 29, 2015
Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progressionDee Sreerangaiah, Michael Grayer, Benjamin A Fisher, et al.
Rheumatology (Oxford, England)|December 23, 2009
Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging studyValentina O Puntmann, Peter C Taylor, Andrew Barr, et al.
Arthritis Research & Therapy|December 25, 2016
Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritisDobrina N Hull, Helen Cooksley, Shilpa Chokshi, et al.
Heliyon|September 6, 2019
Polyurethane-carbon microfiber composite coating for electrical heating of concrete pavement surfacesAlireza Sassani, Ali Arabzadeh, Halil Ceylan, et al.
The Journal of Rheumatology|February 16, 2021
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing SpondylitisPeter C Taylor, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases|February 6, 2026
The positive perspective paradigm: proposal of a model to mitigate the impact of chronic inflammatory arthritis through comprehensive and early interventionMichaël Doumen, Laure Gossec, Mwidimi Ndosi, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
BMC Medicine|December 30, 2025
Cross-speciality collaborative care in complex immune-mediated inflammatory diseases: treating the person living with the conditionPeter C Taylor, Laura Savage, Christine Bundy, et al.
Rheumatology (Oxford, England)|June 3, 2021
Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United KingdomPeter C Taylor, Matthew Woods, Catherine Rycroft, et al.
Pageof 25

Showing results (71-80 of 246) with videos related to

Sort By:
Pageof 25
Annals of the Rheumatic Diseases|August 24, 2011
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trialPeter C Taylor, Emilia Quattrocchi, Stephen Mallett, et al.
Rheumatology (Oxford, England)|August 29, 2015
Quantitative power Doppler ultrasound measures of peripheral joint synovitis in poor prognosis early rheumatoid arthritis predict radiographic progressionDee Sreerangaiah, Michael Grayer, Benjamin A Fisher, et al.
Rheumatology (Oxford, England)|December 23, 2009
Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging studyValentina O Puntmann, Peter C Taylor, Andrew Barr, et al.
Arthritis Research & Therapy|December 25, 2016
Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritisDobrina N Hull, Helen Cooksley, Shilpa Chokshi, et al.
Heliyon|September 6, 2019
Polyurethane-carbon microfiber composite coating for electrical heating of concrete pavement surfacesAlireza Sassani, Ali Arabzadeh, Halil Ceylan, et al.
The Journal of Rheumatology|February 16, 2021
A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing SpondylitisPeter C Taylor, Désirée van der Heijde, Robert Landewé, et al.
Annals of the Rheumatic Diseases|February 6, 2026
The positive perspective paradigm: proposal of a model to mitigate the impact of chronic inflammatory arthritis through comprehensive and early interventionMichaël Doumen, Laure Gossec, Mwidimi Ndosi, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
BMC Medicine|December 30, 2025
Cross-speciality collaborative care in complex immune-mediated inflammatory diseases: treating the person living with the conditionPeter C Taylor, Laura Savage, Christine Bundy, et al.
Rheumatology (Oxford, England)|June 3, 2021
Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United KingdomPeter C Taylor, Matthew Woods, Catherine Rycroft, et al.
Pageof 25